Literature DB >> 27075048

Dystrophic epidermolysis bullosa pruriginosa successfully treated with immunosuppressants.

Tomoko Takahashi1, Yoko Mizutani1, Mitsuru Ito1, Hajime Nakano2, Daisuke Sawamura2, Mariko Seishima3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27075048     DOI： 10.1111/1346-8138.13406

Source DB:  PubMed          Journal:  J Dermatol        ISSN： 0385-2407            Impact factor:   4.005


× No keyword cloud information.
  3 in total

Review 1.  Bullous Diseases in Children: A Review of Clinical Features and Treatment Options.

Authors:  Brittney Schultz; Kristen Hook
Journal:  Paediatr Drugs       Date:  2019-10       Impact factor: 3.022

Review 2.  Small molecule drug development for rare genodermatoses - evaluation of the current status in epidermolysis bullosa.

Authors:  Verena Wally; Manuela Reisenberger; Sophie Kitzmüller; Martin Laimer
Journal:  Orphanet J Rare Dis       Date:  2020-10-19       Impact factor: 4.123

3.  Misdiagnosed dystrophic epidermolysis bullosa pruriginosa: A case report.

Authors:  Zi Wang; Yi Lin; Xing-Wu Duan; Hai-Yan Hang; Xia Zhang; Ling-Ling Li
Journal:  World J Clin Cases       Date:  2021-05-06       Impact factor: 1.337
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.